Management ChangeJul 23, 2026, 04:32 PM
ImageneBio Appoints Yanina Grant-Huerta as CFO
AI Summary
ImageneBio, Inc. announced the appointment of Yanina Grant-Huerta as its new Chief Financial Officer, principal financial officer, and principal accounting officer, effective July 20, 2026. Ms. Grant-Huerta previously served as Chief Accounting Officer at Atara Biotherapeutics and held various financial roles at Amgen Inc. Her compensation package includes an annual base salary of $450,000, eligibility for a 40% annual discretionary bonus, a restricted stock unit award for 65,000 shares, and a stock option award for 95,000 shares.
Key Highlights
- ImageneBio appointed Yanina Grant-Huerta as Chief Financial Officer, effective July 20, 2026.
- Ms. Grant-Huerta will also serve as principal financial officer and principal accounting officer.
- Kristin Yarema, Ph.D., CEO, previously served as interim principal financial officer.
- Ms. Grant-Huerta was Chief Accounting Officer at Atara Biotherapeutics from March 2025 to July 2026.
- Her annual base salary is $450,000, with eligibility for a 40% annual discretionary bonus.
- She will receive a restricted stock unit award for 65,000 shares of common stock.
- She will also receive a stock option award to purchase 95,000 shares of common stock.
Price Impact
More from IMA